Endoplasmic reticulum stress effectors

Endoplasmic reticulum (ER) stress effectors are a diverse group of proteins that orchestrate the Unfolded Protein Response (UPR) to maintain cellular proteostasis. The three primary sensors—PERK (EIF2AK3), IRE1 (ERN1), and ATF6—detect the accumulation of unfolded proteins within the ER lumen and initiate distinct signaling branches. These pathways collectively work to reduce protein synthesis, enhance the folding capacity of the ER through chaperone induction (e.g., BiP/HSPA5), and clear misfolded proteins via ER-associated degradation (ERAD). Under chronic or severe stress, the UPR shifts from an adaptive pro-survival response to a terminal pro-apoptotic program, largely mediated by the downstream effector CHOP (DDIT3). Dysregulation of these effectors is implicated in a wide range of pathologies, including neurodegenerative diseases, metabolic disorders such as type 2 diabetes, and various malignancies. Therapeutic strategies involve the use of small molecule inhibitors or activators to modulate specific UPR branches, such as PERK inhibitors (e.g., GSK2606414) for neuroprotection or IRE1 inhibitors (e.g., KIRA6) for cancer therapy. Chemical chaperones like 4-phenylbutyric acid are also employed to alleviate ER stress by stabilizing protein folding. However, targeting these effectors presents significant challenges, as the UPR is essential for the function of highly secretory cells, leading to potential side effects like pancreatic dysfunction.

Other names

Unfolded protein response effectorsER stress signaling proteinsUPR mediatorsER stress effectors

Modulation of the unfolded protein response (UPR) signaling pathways to restore endoplasmic reticulum proteostasis or induce selective apoptosis in diseased cells.